Puma Biotechnology | PBYI - PE Price to Earnings


Puma Biotechnology reported 13.93 in PE Price to Earnings for its fiscal quarter ending in June of 2024.





Pe Change Date
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
Amgen 19.84 5.47 Mar/2026
Biogen 13.7 0.32 Mar/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Daiichi Sankyo 20.73 1.74 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Exelixis 13.91 588.4 Mar/2026
Gilead Sciences 17.7 2.07 Mar/2026
Glaxosmithkline 11.66 0.28 Dec/2025
Incyte 15.35 0.51 Mar/2026
Moderna 27.22 14.51 Jun/2023
Novartis 20.17 2.32 Mar/2026
Pfizer 9.32 5.16 Mar/2026
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals 25.14 7.03 Mar/2026
Roche Holding 16.09 3.51 Dec/2025
Sarepta Therapeutics 27.27 0 Dec/2025
Takeda 46.52 188.53 Mar/2026
TG Therapeutics 10.76 2.32 Dec/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023
Vertex Pharmaceuticals 25.82 0.33 Mar/2026